ProShare Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-290,153
| Closed | -$53.3M | – | 2390 |
|
|
2021
Q2 | $53.3M | Sell |
290,153
-1,377
| -0.5% | -$236K | 0.16% | 134 |
|
|
2021
Q1 | $44.6M | Buy |
291,530
+33,516
| +13% | +$5.18M | 0.14% | 153 |
|
|
2020
Q4 | $40.3M | Buy |
258,014
+29,300
| +13% | +$3.77M | 0.15% | 147 |
|
|
2020
Q3 | $26.2M | Buy |
228,714
+27,370
| +14% | +$2.95M | 0.12% | 151 |
|
|
2020
Q2 | $22.6M | Buy |
201,344
+15,655
| +8% | +$1.66M | 0.12% | 140 |
|
|
2020
Q1 | $16.7M | Sell |
185,689
-59,965
| -24% | -$5.89M | 0.12% | 142 |
|
|
2019
Q4 | $26.6M | Buy |
245,654
+18,488
| +8% | +$1.98M | 0.12% | 140 |
|
|
2019
Q3 | $22.2M | Buy |
227,166
+7,041
| +3% | +$794K | 0.12% | 137 |
|
|
2019
Q2 | $28.8M | Sell |
220,125
-26,755
| -11% | -$3.45M | 0.17% | 113 |
|
|
2019
Q1 | $33.4M | Buy |
246,880
+1,517
| +0.6% | +$189K | 0.2% | 111 |
|
|
2018
Q4 | $23.9M | Buy |
245,363
+24,774
| +11% | +$2.93M | 0.17% | 121 |
|
|
2018
Q3 | $30.7M | Sell |
220,589
-24,111
| -10% | -$3.02M | 0.21% | 107 |
|
|
2018
Q2 | $30.4M | Sell |
244,700
-23,668
| -9% | -$2.77M | 0.2% | 114 |
|
|
2018
Q1 | $29.9M | Buy |
268,368
+7,435
| +3% | +$889K | 0.19% | 117 |
|
|
2017
Q4 | $31.2M | Buy |
260,933
+52,727
| +25% | +$6.42M | 0.22% | 103 |
|
|
2017
Q3 | $29.2M | Buy |
208,206
+3,041
| +1% | +$413K | 0.27% | 94 |
|
|
2017
Q2 | $25M | Buy |
205,165
+30,098
| +17% | +$3.5M | 0.25% | 91 |
|
|
2017
Q1 | $21.2M | Sell |
175,067
-20,715
| -11% | -$2.67M | 0.22% | 98 |
|
|
2016
Q4 | $24M | Buy |
195,782
+24,065
| +14% | +$2.94M | 0.27% | 87 |
|
|
2016
Q3 | $21M | Sell |
171,717
-27,762
| -14% | -$3.57M | 0.29% | 82 |
|
|
2016
Q2 | $23.3M | Buy |
199,479
+4,537
| +2% | +$644K | 0.3% | 92 |
|
|
2016
Q1 | $27.1M | Sell |
194,942
-45,831
| -19% | -$6.73M | 0.37% | 84 |
|
|
2015
Q4 | $45.9M | Buy |
240,773
+13,602
| +6% | +$2.38M | 0.56% | 32 |
|
|
2015
Q3 | $35.5M | Sell |
227,171
-8,206
| -3% | -$1.5M | 0.5% | 40 |
|
|
2015
Q2 | $42.5M | Sell |
235,377
-4,385
| -2% | -$757K | 0.59% | 28 |
|
|
2015
Q1 | $41.6M | Buy |
239,762
+44,363
| +23% | +$8.03M | 0.49% | 35 |
|
|
2014
Q4 | $36.2M | Buy |
195,399
+50,040
| +34% | +$9.27M | 0.42% | 41 |
|
|
2014
Q3 | $24.1M | Sell |
145,359
-45,716
| -24% | -$7.51M | 0.32% | 50 |
|
|
2014
Q2 | $29.9M | Sell |
191,075
-39,713
| -17% | -$6.27M | 0.39% | 40 |
|
|
2014
Q1 | $35.1M | Buy |
230,788
+93,789
| +68% | +$14.9M | 0.44% | 33 |
|
|
2013
Q4 | $18.2M | Buy |
136,999
+45,794
| +50% | +$5.5M | 0.27% | 65 |
|
|
2013
Q3 | $10.6M | Sell |
91,205
-3,167
| -3% | -$347K | 0.25% | 72 |
|
|
2013
Q2 | $8.71M | Buy |
+94,372
| New | +$9.09M | 0.17% | 103 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM